Bacterial Infections  >>  Pneumovax 23 (23-valent pneumococcal polysaccharide)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD)
NCT01307449: Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

Completed
N/A
88
US
PNEUMOVAX, 23-valent polysaccharide pneumococcal vaccine, Prevnar, 13-valent pneumococcal conjugate vaccine
Emory University, National Institute of Allergy and Infectious Diseases (NIAID)
Pneumococcal Infection
07/17
07/17

Download Options